Medical and care terms
GLP-1: A hormone pathway involved in blood sugar and appetite-related signaling. Some medicines act on GLP-1 receptors.
BMI: Body mass index, a screening calculation based on height and weight. It is not a full health assessment by itself.
Contraindication: A reason a medicine or treatment may not be appropriate for a person.
Side effect: An unwanted or unexpected effect that may happen with a medicine or treatment.
Access and cost terms
Prior authorization: An insurance process where a plan reviews whether it will cover a service or medication.
Cash pay: Paying without insurance coverage, often directly to a program, pharmacy, or provider.
Compounded medication: A medication prepared by a compounding pharmacy. Compounded products are not the same as FDA-approved branded products, and questions about source and oversight matter.
Program terms
Telehealth: Care delivered remotely by phone, video, messaging, or online systems.
Maintenance: The longer-term phase after initial weight changes, focused on follow-up, health habits, and plan adjustment.
Editorial review: A content quality process. It is not the same as medical review by a licensed clinician.